- Clinical Trials
- April 2025
- 60 Pages
Global
From €1791EUR$2,000USD£1,527GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1120EUR$1,250USD£954GBP
- Report
- April 2025
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- March 2025
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- November 2024
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- September 2024
- 200 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- August 2024
- 150 Pages
Global
From €2498EUR$2,789USD£2,129GBP
- Report
- August 2024
- 200 Pages
Global
From €3465EUR$3,869USD£2,954GBP
- Report
- December 2024
- 54 Pages
Global
From €6718EUR$7,500USD£5,726GBP
- Report
- December 2024
Global
From €6718EUR$7,500USD£5,726GBP
- Report
- June 2024
- 112 Pages
Global
From €13431EUR$14,995USD£11,449GBP
- Report
- June 2024
- 38 Pages
Global
From €3578EUR$3,995USD£3,050GBP
- Report
- April 2025
- 225 Pages
Global
From €4031EUR$4,500USD£3,436GBP
- Report
- February 2025
- 135 Pages
Global
From €3910EUR$4,365USD£3,333GBP
€4344EUR$4,850USD£3,703GBP
- Report
- November 2024
- 130 Pages
United States
From €5329EUR$5,950USD£4,543GBP
- Report
- February 2025
- 133 Pages
Middle East
From €3045EUR$3,400USD£2,596GBP
€3583EUR$4,000USD£3,054GBP
- Report
- April 2025
- 135 Pages
United States
From €2239EUR$2,500USD£1,909GBP
- Report
- February 2023
- 340 Pages
Global
From €4796EUR$5,542USD£3,950GBP
- Report
- April 2018
- 168 Pages
Global
From €2463EUR$2,750USD£2,100GBP
- Report
- December 2022
- 231 Pages
United States
From €2351EUR$2,625USD£2,004GBP
€4702EUR$5,250USD£4,009GBP

The Ovarian market is a segment of the Women's Health industry that focuses on the diagnosis, treatment, and prevention of ovarian diseases. It includes products and services related to the diagnosis, treatment, and prevention of ovarian cancer, ovarian cysts, and other ovarian disorders. The market also includes products and services related to fertility, contraception, and hormone replacement therapy.
The Ovarian market is driven by the increasing prevalence of ovarian diseases, the growing awareness of the importance of early diagnosis and treatment, and the increasing demand for fertility treatments. Additionally, the development of new technologies and treatments for ovarian diseases is expected to drive the market growth.
Some companies in the Ovarian market include AbbVie, AstraZeneca, Bayer, Merck, Novartis, Pfizer, and Roche. Show Less Read more